<DOC>
	<DOC>NCT00198484</DOC>
	<brief_summary>The purpose of this study is to determine whether Vitrase (hyaluronidase for injection) is effective as a spreading agent for other injected drugs prior to ocular surgery</brief_summary>
	<brief_title>Evaluation of Vitrase as a Spreading Agent</brief_title>
	<detailed_description />
	<criteria>Scheduled for an ophthalmic surgical procedure Documented history of hypersensitivity to hyaluronidase or any other ingredient in Vitrase Known history of hypersensitivity reaction to bee or wasp venom Needing enhanced absorption and dispersion of dopamine, alpha agonist drugs, furosemide, the benzodiazepines, or phenytoin Inflammation or apparent clinical signs of infection in the area where Vitrase was to be injected</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Adjuvants, Anesthesia</keyword>
	<keyword>Spreading Factor</keyword>
</DOC>